TScan Therapeutics Reports Full Year 2021 Financial Results and Highlights Key 2022 Priorities March 11, 2022
Colorescience® Expands Award-Winning All Calm® Line with New All Calm® Multi-Correction Serum to Address Sensitive Skin Concerns January 25, 2022
TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-100 for the Treatment of Hematologic Malignancies January 24, 2022
